FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Drug Ad Spending Drops

[ Price : $8.95]

Media trackers tell USA Today that drug ad spending has dropped significantly in the first half of this year.

Senators Probe Device Firms Payments to Docs

[ Price : $8.95]

Sens. Grassley and Kohl seek information on device company funding to researchers associated with the Cardiovascular Research Foun...

Appeals Court Affirms Barr/Bayer Cipro Pact

[ Price : $8.95]

The U.S. Court of Appeals for the Federal Circuit upholds a lower court finding that a Barr Pharmaceuticals and Bayer Corp. patent...

60 New FDA Foreign CSOs to Cost $30 Million

[ Price : $8.95]

HHS secretary Michael Leavitt says 60 new FDA foreign consumer safety officers at outposts next year will cost $30 million dollars...

FDA Grants Full Approval for Ontak BLA

[ Price : $8.95]

FDA grants full approval to a previously accelerated-approved Eisai Corp. BLA for Ontak.

India Says U.S. Firms Pushed FDA to Ranbaxy Ban

[ Price : $8.95]

Indian government officials say anti-competitive pressures on FDA from U.S. drug companies are responsible for agency enforcement ...

NDA First Cycle Review is Key: Parexel

[ Price : $8.95]

Parexel consulting says there are significant advantages for companies that put effort into gaining FDA approval of new drugs on t...

FDA OKs Cypress Generic Zyrtec

[ Price : $8.95]

FDA approves a Cypress Pharmaceutical ANDA for prescription and over-the-counter versions of McNeil Consumer Healthcare' Zyrtec Or...

Study Finds Health Statistics Illiteracy

[ Price : $8.95]

Researchers say drug companies sometimes make use of peoples statistical illiteracy to promote their products unfairly.

FDA-Industry Panel Answers Drug Safety-efficacy Questions

[ Price : $8.95]

A panel of experts from FDA and the pharmaceutical industry answer wide-ranging questions from attendees at a DIA-sponsored drug s...